Log in
0 followers
Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.
Industries
Headquarters
Stage
Employees
Links
James McCullough
5 members
3 members
BioMarin Pharmaceutical
22 followers
Adaptive Biotechnologies
11 followers
Agilent Technologies
60 followers
Regeneron
77 followers
Verve Therapeutics
53 followers
Discover companies